Clients – ranging from startups to multinational public companies, in a broad range of industries – look to Anne for her skillful ability to advise on issues related to corporate and employment law, including executive compensation, employee benefits, securities law, and corporate governance.

Anne is also a key member of the firm’s multidisciplinary ESG practice, helping corporate boards, companies, and their investors navigate a broad range of environmental, social, and governance considerations. She is also a member of the firm’s FinTech, Blockchain, and Digital Assets practice, where she regularly advises on compensation and benefits programs involving cryptocurrency and digital assets.

Part of Anne’s practice involves helping clients create, implement and administer equity and executive compensation arrangements and programs, including equity plans, phantom equity arrangements, incentive plans, deferred compensation plans, change-in-control arrangements, and severance and employment agreements. She also advises with respect to tax, corporate and securities law concerns that arise in connection with such plans and arrangements. She advises and represents a broad range of public and private companies, boards of directors and compensation committees in these matters. She also assists executives with negotiation of their compensation packages, and works closely with senior executives and founders to implement 10b5-1 plans and complex diversification strategies. Additionally, Anne has played a significant role in many public offerings, SPAC transactions and merger and acquisition transactions, representing companies in connection with complex employee benefits and compensation-related aspects.

On the corporate side of her practice, Anne leverages her broad-ranging experience to counsel clients on the intricacies of the federal securities laws. Anne advises public companies and registrants in preparing required disclosure filings and shareholder materials, and helps companies develop ESG strategies, consider disclosure requirements of director and executive compensation, understand cybersecurity issues, and address institutional investors and proxy advisory firm considerations.

In addition, Anne assists companies in implementing and administering a range of policies to address governance obligations, including insider trading, anti-hedging and claw back policies. She also provides guidance on securities laws requirements to clients involved in public and private M&A and private equity and leveraged buyout transactions, as well as debt and equity financings, divestitures, spinoffs, and IPOs.

Closing the 8-K Insider Trading Gap

February 28, 2020 | Advisory | By Anne Bruno

On January 13th, the US House of Representatives overwhelmingly voted to pass legislation designed to prevent public company insiders from trading on corporate information ahead of the investing public during the period between the filing of a Form 8-K and the event triggering the filing (the “8-K gap period”). The US Senate version of the 8-K Trading Gap Act of 2019 (the “Bill”) was introduced on January 17th and awaits consideration.

January 23, 2020 | Advisory | By Megan Gates, John Condon, Anne Bruno

Read about regulatory developments affecting public companies as they prepare for fiscal year-end Securities and Exchange Commission filings and annual shareholder meetings.

June 17, 2019 | Blog | By Alexander Song, Anne Bruno

On May 31, 2019, in Stein v. Blankfein, et. al., the Delaware Court of Chancery reaffirmed the Delaware Supreme Court’s holding in In re: Investors Bancorp, Inc. Stockholder Litigation (more information here) that the “entire fairness” standard applies with regard to director approval of director compensation. The Stein case builds on the precedent set in Investors Bancorp and provides additional insights.

January 29, 2019 | Advisory | By Anne Bruno, Megan Gates

Each year, Mintz provides an analysis of the regulatory developments that impact public companies as they prepare for their fiscal year-end filings with the Securities and Exchange Commission (the SEC) and their annual shareholder meetings. In this memorandum, we discuss key considerations to keep in mind as you embark upon the year-end reporting process in 2019.

January 30, 2018 | Advisory | By Pamela Greene, Anne Bruno, Megan Gates

As our clients and friends know, each year Mintz Levin provides an analysis of the regulatory developments that impact public companies as they prepare for their fiscal year-end filings with the Securities and Exchange Commission (the “SEC”) and their annual shareholder meetings.

Read less

Mintz Promotes Nine to Member

December 15, 2021

Mintz Advises JMP Group in Sale to Citizens Financial Group

November 16, 2021

Mintz Advises Cardurion Pharmaceuticals in Investment of up to $300 Million from Bain Capital

November 02, 2021

Mintz advised Cardurion Pharmaceuticals, Inc., a biotechnology company developing novel therapeutics to treat heart failure and other cardiovascular diseases, in a private investment of up to $300 million from Bain Capital Life Sciences and Bain Capital Private Equity that will enable the Boston-based company to expand its drug discovery programs.

XL Fleet Completes Merger with Pivotal Investment Corporation II, a Special Purpose Acquisition Company, Begins Trading on NYSE

December 23, 2020

‘Too Old’ to Be CEO — Bias Charges in Succession Plan

November 6, 2020

In Agenda, a Financial Times publication, Mintz Special Counsel Anne Bruno was quoted on company succession planning and how boards can effectively communicate the process and decision to candidates.